Fortuna: 66 M $ al 31/05/2026
En la actualidad, Pascal Soriot es Consejero Delegado y Director Ejecutivo de AstraZeneca Plc y Presidente de AstraZeneca AB (filial de AstraZeneca Plc). También forma parte del consejo de Pharmaceutical Research & Manufacturers of America y de Acerta Pharma BV. Pascal Soriot fue anteriormente Director de Ventas de Distrito en Roussel NZ Ltd., Director y Jefe Ejecutivo del Grupo Roche en Genentech, Inc., Director de Operaciones de Roche Pharmaceuticals, Inc., Director de Operaciones en Sanofi-Aventis U.S. LLC y Vicepresidente de Asia Pacífico en Hoechst Marion Rousel JP. Obtuvo un MBA en el cole des Hautes tudes Commerciales de París y un doctorado en el cole Nationale Vtrinaire d'Alfort.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ASTRAZENECA PLC 0,02 % | 14/05/2026 | 355.461 ( 0,02 % ) | 66 M $ | 31/05/2026 |
| 19/03/2026 | 2.683 ( 0 % ) | 363 627 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ASTRAZENECA PLC | Director Ejecutivo | 01/10/2012 |
| AGILENT TECHNOLOGIES, INC. | Director/Miembro de la Junta | 20/05/2025 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Director/Miembro de la Junta | - |
AstraZeneca Colombia SAS | Director Ejecutivo | 01/10/2012 |
AstraZeneca Österreich GmbH
 AstraZeneca Österreich GmbH BiotechnologyHealth Technology Develops, produces and markets medicines for treatment of cardiovascular, metabolic, oncology, respiratory, infectious and autoimmune diseases | Director Ejecutivo | - |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Director Ejecutivo | - |
AstraZeneca Holding GmbH
 AstraZeneca Holding GmbH Financial ConglomeratesFinance Functions as an investment holding company | Director Ejecutivo | - |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Director Ejecutivo | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Director/Miembro de la Junta | - |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ ░░░░ | ░░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 21 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Chugai Pharmaceutical Co., Ltd.
 Chugai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures & sells pharmaceutical products | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Commercial Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
Hoechst Marion Rousel JP
 Hoechst Marion Rousel JP Miscellaneous Commercial ServicesCommercial Services Conducts medical research | Commercial Services |
AstraZeneca Österreich GmbH
AstraZeneca Österreich GmbH BiotechnologyHealth Technology Develops, produces and markets medicines for treatment of cardiovascular, metabolic, oncology, respiratory, infectious and autoimmune diseases | Health Technology |
AstraZeneca Colombia SAS | |
AstraZeneca Holding GmbH
AstraZeneca Holding GmbH Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Roussel NZ Ltd. | |
École Nationale Vétérinaire d'Alfort
 École Nationale Vétérinaire d'Alfort Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
The Sustainable Markets Initiative |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
